“…Although the screening utility of the CDT in dementia has been ascertained (Peters & Pinto, 2008), its utility in mild cognitive impairment (MCI) remains controversial. K. S. Lee et al (2008) investigated this issue using four scoring methods-namely, the Freedman et al (1994), the Rouleau, Salmon, Butters, Kennedy, and McGuire (1992), the Todd, Dammers, Adams, Todd, and Morrison (1995) methods and the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) method (J. H. Lee, Lee, & Lee, 2002). These authors found that the sensitivity and specificity values of these four quantitative scoring methods were not acceptable and concluded that although qualitative analyses (such as the analysis of error types) may help the identification of MCI patients, the CDT alone is not sufficient as a screening tool in this population.…”